Evaluation of Ceftobiprole Activity against a Variety of Gram-Negative Pathogens, Including Escherichia coli, Haemophilus influenzae (β-Lactamase Positive and β-Lactamase Negative), and Klebsiella pneumoniae, in a Rabbit Meningitis Model

Impact of Different Carbapenems and Regimens of Administration on Resistance Emergence for Three Isogenic Pseudomonas aeruginosa Strains with Differing Mechanisms of Resistance

(2010) A. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and Pharmacodynamics of Ceftobiprole, an Anti-MRSA Cephalosporin with Broad-Spectrum Activity

(2009) Bindu Murthy et al.   CLINICAL PHARMACOKINETICS

Spontaneous epidural abscess: Analysis of 15 cases with emphasis on diagnostic and prognostic factors

(2009) Julio J. González-López et al.   European Journal of Internal Medicine

In vitro antimicrobial activity of silver-processed catheters for neurosurgery

(2009) R. Bayston et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Surgical Site Infections after Elective Neurosurgery

(2009) Rafael Augusto Castro Santiago Brandão   NEUROSURGERY

Efficacies of Ceftobiprole Medocaril and Comparators in a Rabbit Model of Osteomyelitis Due to Methicillin-Resistant Staphylococcus aureus

(2008) L.-Y. Yin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial activity of ceftobiprole, a novel anti–methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005–2006)

(2008) Thomas R. Fritsche et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE